Dr. Fischer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
675 Nelson Rising Lane, Room 292
Box 1207
San Francisco, CA 94158
Summary
- Dr. Luke Fischer (he/his) is a neurologist-neuroscientist with an interest in Lewy body disease. He currently is a NINDS UE5 research fellow in the laboratory of Dr. Lea Grinberg.
Education & Training
- University of California San FranciscoResearch Fellowship, Neuropathology, 2024
- University of California (San Francisco)Fellowship, Behavioral Neurology, 2022 - 2024
- University of Alabama Medical CenterChief Residency, Neurology, 2021 - 2022
- University of Alabama Medical CenterResidency, Neurology, 2018 - 2022
- Michigan State University College of Human MedicineClass of 2018, M.D., (Dual M.D./Ph.D. Program)
- Michigan State University College of Human MedicinePost-Doctoral Fellowship, 2015 - 2016
- Michigan State UniversityPhD, Neuroscience, 2010 - 2015
- Michigan State UniversityBS, Biochemistry and Molecular Biology, With Honor, 2006 - 2010
- Michigan State UniversityBA, Philosophy, With Honor, 2006 - 2010
Certifications & Licensure
- CA State Medical License 2022 - 2026
- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 9 citationsClinicopathological correlation of cerebrospinal fluid alpha-synuclein seed amplification assay in a behavioral neurology autopsy cohort.Niyatee Samudra, D Luke Fischer, Steven Lenio, Argentina Lario Lago, Peter A Ljubenkov
Alzheimer's & Dementia. 2024-05-01 - 2 citationsA Precision Medicine Approach to Dementia Care: Syndrome, Etiology, and Copathology.D Luke Fischer, William W Seeley
Practical Neurology. 2023-07-01 - rs10501087, rs1491850 and rs11030094 polymorphisms associated with delayed progression in early-stage Parkinson's disease.D Luke Fischer, Peggy Auinger, John L Goudreau, Katrina L Paumier, Allyson Cole-Strauss
Frontiers in Neurology. 2022-01-01
Professional Memberships
- Member
- American Neurological AssociationMember
- Member
- Member
- Member
External Links
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: